Hitoshi Zembutsu

6PUBLICATIONS
9CO-AUTHORS
Cancer geneticsHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 21, 2022
Association between genetic variants and the risk of nivolumab-induced immune-related adverse events.

Chihiro Udagawa, Mari Hara Nakano, Teruhiko Yoshida

|Feb 08, 2022
The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.

Niclas Björn, Ingrid Jakobsen, Chihiro Udagawa

|Sep 28, 2020
Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs.

Chihiro Udagawa, Yasushi Sasaki, Yasuhiro Tanizawa

|Aug 12, 2020
Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy.

Chihiro Udagawa, Hitoshi Zembutsu

|Jun 23, 2020
Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence.

Satoshi Murahashi, Takashi Akiyoshi, Takeshi Sano

|Oct 05, 2019
Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.

Chihiro Udagawa, Hidehito Horinouchi, Kouya Shiraishi

Pageof 1

Frequent Collaborators

4 joint publications

Chihiro Udagawa

1 joint publications

Satoshi Murahashi

1 joint publications

Takashi Akiyoshi

1 joint publications

Yosuke Fukunaga